
Moderna’s coronavirus vaccine fully protects children aged 12 to 17, the company announced Tuesday. In a clinical trial that included more than 3,700 young volunteers, there were no cases of symptomatic COVID-19 infection in the two-thirds of participants who received both doses of the vaccine, which translates into an efficacy rate of 100%. That’s the… read on > read on >